New and updated preclinical and clinical data to be presented by biopharma firms at American Society of Clinical Oncology annual meeting, including: Aadi, Adagene, Adaptimmune, Adicet, Advaxis, Amgen, Aura, Biomea.

Australia’s Therapeutic Goods Administration (TGA) has made a range of changes to its medical device regulations in recent years that have largely been driven by the need to keep pace with changing technologies, TGA head John Skerritt said during the Ausmedtech 2022 annual conference in Melbourne, Australia.

New and updated preclinical and clinical data presented by biopharma firms at Digestive Disease Week 2022, including: Ardelyx, Ferring, Ironwood, Janssen, Phathom, Rebiotix, Redhill, Second Genome.

Pharma companies agree that data is king, since after all, their drugs get approved based on the quality of their data.

Perianal fistulas in Crohn's disease represent a severe complication of the disease. Researchers used a recently established Crohn's perianal fistula rat model to test a novel and proprietary biodegradable nanofiber-hydrogel composite (NHC) loaded with rat adipose-derived stem cells (ADSCs).